Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ1175-1,76
KB993-6,32
PKN68,8368,85-0,35
Msft436,68436,740,32
Nokia4,4244,430,66
IBM248,95249,131,47
Mercedes-Benz Group AG53,8353,841,03
PFE24,0124,02-0,76
05.05.2025 17:21:42
Indexy online
AD Index online
select
AD Index online
 

  • 05.05.2025 17:22:01
Nu Skin Enter (NUS, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
6,12 -1,13 -0,07 59 875
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 05.05.2025
Popis společnosti
Obecné informace
Název společnostiNU Skin Enterprises Inc
TickerNUS
TickerNUS.B
Kmenové akcie:Ordinary Shares Class A
Kmenové akcie:Ordinary Shares
RICNUS.B
RICNUS
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.12.2024
Počet zaměstnanců k 31.12.2024 3 100
Akcie v oběhu k 01.04.2025 49 409 222
MěnaUSD
Kontaktní informace
UliceATTN: D. MATTHEW DORNY
MěstoPROVO
PSČ84601
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 013 456 100
Fax18013455999

Business Summary: Nu Skin Enterprises Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. It offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, NU Skin Enterprises Inc revenues decreased 12% to $1.73B. Net loss totaled $146.6M vs. income of $8.6M. Revenues reflect Nu Skin segment decrease of 18% to $1.45B. Dividend per share decreased from $1.56 to $0.24. Basic Earnings per Share excluding Extraordinary Items decreased from $0.17 to -$2.95.
Odvětvová klasifikace
TRBC2009Personal Products
TRBC2012Personal Products (NEC)
RBSS2004Personal Products
MGINDUSTRYMajor Drugs
MGSECTORHealthcare
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICSToilet Preparation Manufacturing
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Toilet Preparation Manufacturing
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
NAICS1997Toilet Preparation Manufacturing
SICDrugs/proprietaries/sundries
SICDrugs/proprietaries/sundries
SICToilet Preparations



  • Poslední aktualizace: 05.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the BoardSteven Lund7101.01.1996
President, Chief Executive Officer, DirectorRyan Napierski5101.09.202108.09.2015
Chief Financial Officer, Executive Vice PresidentJames Thomas4624.07.202331.03.2023
Executive Vice President, General CounselChayce Clark4201.08.202101.08.2021
Executive Vice President, Chief Product OfficerSteven Hatchett53
Executive Vice President and President of Global SalesJustin Keisel51